BMJ 1994;308:867-868 (2 April)
Editorials
Vitamin K for neonates: the controversy
Giving neonates vitamin K to prevent vitamin K deficiency bleeding (a more informative and accurate term than the venerable "haemorrhagic disease of the newborn") has been controversial almost since it began. In the 1950s synthetic menadione (Synkavit, Roche), commonly used in doses of 30 mg or more,1 was linked with haemolysis in premature babies2 and with kernicterus.3 In the 1960s and 1970s, when intramuscular phytomenadione (Konakion, Roche) 1 mg was the standard prophylaxis in Britain, there was argument over whether it should be given selectively or to all babies.4 In the 1980s some babies mistakenly received the injection of ergometrine-oxytocin meant for their mothers with disastrous results,5 and there was debate about whether a single oral dose of vitamin K could give the same protection as an intramuscular dose.6 In the early 1990s cases of vitamin K deficiency bleeding were described in babies who had received a single oral dose . . . [Full text of this article]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
This article has been cited by other articles:
-
(1998). Which vitamin K preparation for the newborn?. DTB
36: 17-19
[Abstract]
[Full text]
-
McKinney, P. A, Juszczak, E., Findlay, E., Smith, K.
(1998). Case-control study of childhood leukaemia and cancer in Scotland: findings for neonatal intramuscular vitamin K. BMJ
316: 173-177
[Abstract]
[Full text]
-
von Kries, R., Gobel, U., Hachmeister, A., Kaletsch, U., Michaelis, J.
(1996). Vitamin K and childhood cancer: a population based case-control study in Lower Saxony, Germany. BMJ
313: 199-203
[Abstract]
[Full text]
-
Newburn, M, Dodds, R
(1994). Vitamin K for neonates. BMJ
309: 668b-669
[Full text]
-
Slattery, J
(1994). Vitamin K for neonates. BMJ
308: 1635-1635
[Full text]